Gemifloxacin

In the US, Gemifloxacin (gemifloxacin systemic) is a member of the drug class quinolones and is used to treat Bronchitis, Pneumonia and Strep Throat.

US matches:

• Gemifloxacin


• Gemifloxacin Mesylate

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01MA15

CAS registry number (Chemical Abstracts Service)

0204519-64-2

Chemical Formula

C18-H20-F-N5-O4

Molecular Weight

389

Therapeutic Category

Antibacterial: Gyrase inhibitor

Chemical Name

(+-)-7-[3-(aminomethyl)-4-oxo-1-pyrrolidinyl]-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acid, 7(4)-(Z)-(O-methyloxime)

Foreign Names

• Gemifloxacinum (Latin)
• Gemifloxacin (German)
• Gemifloxacine (French)
• Gemifloxacino (Spanish)

Generic Names

• LB 20304 (IS)
• Gemifloxacin Mesylate (OS: USAN)
• LB 20304 a (IS)
• SB 265805 (IS)

Brand Names

• Factiv
  Verofarm, Russian Federation



• Gametop
  Solitaire, India



• Gamibit
  Cubit, India



• Le-Gami
  Lexus, India



• Factive
  Abbott, Canada; Aspen Pharmacare, South Africa; GeneSoft, South Korea; Oscient, United States; Pfizer, Mexico; Tabuk Pharmaceutical, Oman

International Drug Name Search

Glossary

IS	Inofficial Synonym
OS	Official Synonym
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.